Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2012, Vol. 17 ›› Issue (9): 978-982.

Previous Articles     Next Articles

The inhibitory effect of juglone on the metastasis of skin melanoma cell line B16F10

CHEN Li1, ZHANG Jian2, WANG Si-ying1, HUANG De-wu1, GU Wei-wang2   

  1. 1Laboratory Animal Center,Anhui Medical University,Hefei 230032, Anhui,China;
    2Laboratory Animal Center&Department of Comparative Medicine, Southern Medical University, Guangzhou 510515, Guangdong,China;
  • Received:2011-12-27 Revised:2012-08-02 Published:2012-09-25

Abstract: AIM: To investigate the inhibitory effect of juglone on the metastasis of skin melanoma cell line B16F10. METHODS: B16-F10 cells were injected into the tail veins of C57BL/6 mice to establish an experimental lung metastasis model, and the effect of juglone on lung metastasis was observed.RESULTS: The number of metastases in the animals that were given juglone 4.5,3,1.5 and 7.5 mg·kg-1·d-1 was significantly reduced as compared with the vehicle control(P<0.05),and the inhibition rates were 27.30%, 55.35%, 31.52%, 25.34%, respectively.Compared with the positive control group, the inhibitory rate of 3 mg/kg juglone was no significant difference (P>0.05). CONCLUSION: Juglone could inhibit melanoma metastasis of B16F10.

Key words: Juglone, B16F10 cell, Hematogenous metastasis

CLC Number: